Cytokinetics may be counting down the days until the FDA decides whether to approve its cardiovascular drug aficamten. | ...

Medtronic posted a slate of strong quarterly financial results this morning, with its cardiovascular device portfolio pushing ...

Vanda Pharmaceuticals’ expansion into the booming GLP-1 market has cleared a midphase test. | Vanda Pharmaceuticals’ ...

The investment bank Jefferies had been running its healthcare conference in London for 14 years as a reasonably intimate ...

Cornerstone Robotics secured about $200 million in its second round of financing this year, which the Hong Kong-based company ...

Roche has reported another phase 3 win for its oral selective estrogen receptor degrader (SERD). Success at a planned interim ...

On its face, Biogen’s May 2024 acquisition of Human Immunology Biosciences (HI-Bio) | On its face, there wasn’t much notable ...

The startup incubator MedTech Innovator only launched in 2013, but it has had an immense impact on the industry. | Three MedTech Innovator startups showed off their diagnostic tech at the American ...

Through a collaboration with Edwards Lifesciences, Philips is rolling out new artificial intelligence tools designed to ...

Genmab has shed another antibody-drug conjugate from its April 2024 acquisition of ProfoundBio. | Genmab has shed another ...

After laying off most of its staff and partnering away its phase 3 cancer asset earlier this year, precision oncology outfit ...

Amid its multi-front legal battle with Apple over its smartwatch’s blood oxygen sensors, Masimo has claimed new ...